MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Operating Income Summary of MIRA Pharmaceuticals, Inc.

  • MIRA Pharmaceuticals, Inc.'s latest annual operating income in 2023 was -8.52 Million USD , down -20.97% from previous year.
  • MIRA Pharmaceuticals, Inc.'s latest quarterly operating income in 2024 Q2 was -1.73 Million USD , up 2.12% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported an annual operating income of -7.04 Million USD in 2022, down -227.48% from previous year.
  • MIRA Pharmaceuticals, Inc. reported an annual operating income of -2.15 Million USD in 2021, down -3082.26% from previous year.
  • MIRA Pharmaceuticals, Inc. reported a quarterly operating income of -1.73 Million USD for 2024 Q2, up 2.12% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported a quarterly operating income of -1.33 Million USD for 2023 Q1, up 0.62% from previous quarter.

Annual Operating Income Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Operating Income of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year Operating Income Operating Income Growth
2023 -8.52 Million USD -20.97%
2022 -7.04 Million USD -227.48%
2021 -2.15 Million USD -3082.26%
2020 -67.63 Thousand USD 0.0%

Peer Operating Income Comparison of MIRA Pharmaceuticals, Inc.

Name Operating Income Operating Income Difference
Amgen Inc. 7.89 Billion USD 100.108%
AstraZeneca PLC 8.19 Billion USD 100.104%
Biogen Inc. 1.29 Billion USD 100.657%
Gilead Sciences, Inc. 7.6 Billion USD 100.112%
Scilex Holding Company -105.43 Million USD 91.913%
Scilex Holding Company -105.43 Million USD 91.913%